Phase II Study of TKI258 in Advanced Urothelial Carcinoma

Clinical trial NCT00790426 · COMPLETED

Trial details

NCT number: NCT00790426
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Cancer

Start date: 2010-03-01
Primary completion: 2012-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.